Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.56 |
| ▸ | MAPT | P10636 | 3/20 | 0.56 |
| ▸ | USP2 | O75604 | 3/20 | 0.56 |
| ▸ | LMNA | P02545 | 3/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.56 |
| ▸ | RECQL | P46063 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.54 |
| ▸ | HPGD | P15428 | 2/20 | 0.54 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.50 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 5/20 | 0.48 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.47 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.42 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.42 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.40 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL592903 | 1.00 | CYP3A4 (0.56) | CYP3A4MAPTUSP2LMNASMN1; SMN2 | |
| SCHEMBL2837141 | 1.00 | CYP3A4 (0.56) | CYP3A4MAPTUSP2LMNASMN1; SMN2 | |
| SCHEMBL2839053 | 1.00 | CYP3A4 (0.56) | CYP3A4MAPTUSP2LMNASMN1; SMN2 | |
| SCHEMBL8463541 | 1.00 | CYP3A4 (0.56) | CYP3A4MAPTUSP2LMNASMN1; SMN2 | |
| SCHEMBL2841007 | 1.00 | CYP3A4 (0.56) | CYP3A4MAPTUSP2LMNASMN1; SMN2 | |
| SCHEMBL2836294 | 1.00 | CYP3A4 (0.56) | CYP3A4MAPTUSP2LMNASMN1; SMN2 | |
| SCHEMBL2838417 | 1.00 | CYP3A4 (0.56) | CYP3A4MAPTUSP2LMNASMN1; SMN2 | |
| SCHEMBL816892 | 1.00 | CYP3A4 (0.56) | CYP3A4MAPTUSP2LMNASMN1; SMN2 | |
| SCHEMBL2837462 | 1.00 | CYP3A4 (0.56) | CYP3A4MAPTUSP2LMNASMN1; SMN2 | |
| SCHEMBL28416989 | 1.00 | CYP3A4 (0.56) | CYP3A4MAPTUSP2LMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 283 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018145219-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ADDICTIONS BY MEANS OF AVERSIVE COUNTERCONDITIONING | SERANI MOSTAZAL JORGE (CL) | 2018-08-16 | — | — | WO | claimed |
| EP-3129347-A1 | REACTIONS IN THE PRESENCE OF RUTHENIUM COMPLEXES | California Institute of Technology (US) | 2017-02-15 | — | — | EP | claimed |
| WO-2015157736-A1 | REACTIONS IN THE PRESENCE OF RUTHENIUM COMPLEXES | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2015-10-15 | — | — | WO | claimed |
| US-20150284313-A1 | REACTIONS IN THE PRESENCE OF RUTHENIUM COMPLEXES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2015-10-08 | — | — | US | claimed |
| EP-2072083-B1 | Utilisation of 2.4'-dimethyl-propiophenon as an aroma | SYMRISE AG (DE) | 2012-02-15 | — | — | EP | claimed |
| US-20090162308-A1 | USE OF 2,4'-DIMETHYLPROPIOPHENONE AS A FRAGRANCE SUBSTANCE | SYMRISE GMBH & CO. KG (DE) | 2009-06-25 | — | — | US | claimed |
| US-20060166857-A1 | 4,8-Dimethyl-7-nonen-2-one and 4,8-dimethylnonan-2-one used as perfumes | SYMRISE GMBH & CO. KG (DE) | 2006-07-27 | — | — | US | claimed |
| US-6844302-B1 | Encapsulated flavor and fragrance | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2005-01-18 | — | — | US | claimed |
| US-6126930-A | REDUCING TRIGEMINAL STIMULATION FROM AN ATOMIZED ALCOHOL | THE PROCTER & GAMBLE COMPANY (US) | 2000-10-03 | — | — | US | claimed |
| EP-0986367-A1 | SPRAY COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2000-03-22 | — | — | EP | claimed |
| WO-1998035651-A1 | SPRAY COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1998-08-20 | — | — | WO | claimed |
| EP-0099572-B1 | DISPROPORTIONATION OF FUNCTIONAL OLEFINS | PHILLIPS PETROLEUM COMPANY (US) | 1989-09-06 | — | — | EP | claimed |
| US-4560792-A | WITH HYDROCARBYL MONOOLEFIN IN PRESENCE OF TUNGSTEN CARBENE COMPLEX AND HALIDE(OR OXYHALIDE)CATALYST | PHILLIPS PETROLEUM COMPANY (US) | 1985-12-24 | — | — | US | claimed |
| EP-0099572-A1 | Disproportionation of functional olefins | PHILLIPS PETROLEUM COMPANY (US) | 1984-02-01 | — | — | EP | claimed |
| US-20260096991-A1 | BIODEGRADABLE MICROCAPSULES AND METHOD FOR THEIR PREPARATION | XAMPLA LTD (GB) | 2026-04-09 | — | — | US | disclosed |
| EP-4489592-B1 | BIODEGRADABLE MICROCAPSULES AND A METHOD FOR THEIR PREPARATION | XAMPLA LTD (GB) | 2025-12-24 | — | — | EP | disclosed |
| EP-3583088-B1 | SYNTHESIS OF PHEROMONES AND RELATED MATERIALS VIA OLEFIN METATHESIS | PROVIVI INC (US) | 2025-09-10 | — | — | EP | disclosed |
| US-4818442-A | Disproportionation process | PHILLIPS PETROLEUM COMPANY (US) | 1989-04-04 | — | — | US | disclosed |
| US-4560792-A | WITH HYDROCARBYL MONOOLEFIN IN PRESENCE OF TUNGSTEN CARBENE COMPLEX AND HALIDE(OR OXYHALIDE)CATALYST | PHILLIPS PETROLEUM COMPANY (US) | 1985-12-24 | — | — | US | disclosed |
| EP-0099572-A1 | Disproportionation of functional olefins | PHILLIPS PETROLEUM COMPANY (US) | 1984-02-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260096991-A1 | BIODEGRADABLE MICROCAPSULES AND METHOD FOR THEIR PREPARATION | PCTP, CLK4, MTCL3 | CYP3A4 4797/4885MAPT 146/4885USP2 831/4885 |
| US-20090162308-A1 | USE OF 2,4'-DIMETHYLPROPIOPHENONE AS A FRAGRANCE SUBSTANCE | CYP1B1, CYP4A22, ROS1 | CYP3A4 65/4885MAPT 2104/4885USP2 2366/4885 |
| US-20150284313-A1 | REACTIONS IN THE PRESENCE OF RUTHENIUM COMPLEXES | DDC, LTC4S, CYCS | CYP3A4 31/4885MAPT 4101/4885USP2 3181/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.